Physician profile
Lee Glenn
NPI 1770921421
$1,565.86
in general payments reported to CMS, 2019-2025
22 companies · $243 in 2025
The $243 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2020: $202 · 2021: $195 · 2022: $186 · 2023: $101 · 2024: $128 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $202.98 | 2019-2022 | |
| Glaxosmithkline, LLC. | $198.26 | 2019-2021 | |
| Pfizer INC. | $189.23 | 2019-2025 | |
| Cranial Technologies, INC | $128.73 | 2019-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $97.71 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.82 | 2019-2021 | |
| Corium, LLC | $84.51 | 2022-2024 | Azstarys |
| Baxter Healthcare | $81.33 | 2022 | |
| Sanofi-Aventis U.S. LLC | $71.63 | 2025 | |
| Sanofi Pasteur INC. | $66.73 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $64.13 | 2023-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Adlon Therapeutics L.P. | $57.21 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $54.10 | 2025 | Jornay Pm |
| Genentech USA, INC. | $40.38 | 2019-2021 | |
| Neuraxis, INC. | $28.84 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $22.80 | 2023 | |
| Eyevance Pharmaceuticals LLC | $17.61 | 2021 | |
| Ironwood Pharmaceuticals, INC | $17.34 | 2024 | |
| Alexion Pharmaceuticals, INC. | $15.47 | 2019 | |
| Shire North American Group INC | $14.13 | 2019 | |
| Neos Therapeutics, LP | $12.04 | 2020 | |
| Mission Pharmacal Company | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Glenn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.